corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 12197

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Tuma RS.
Trend toward noninferiority trials may mean more difficult interpretation of trial results.
J Natl Cancer Inst 2007 Dec 5; 99:(23):1746-8
http://jnci.oxfordjournals.org/cgi/content/full/99/23/1746

Keywords:
Antineoplastic Agents/therapeutic use* Clinical Trials as Topic/methods* Clinical Trials as Topic/standards Data Interpretation, Statistical* Drug Approval Drug Industry Humans Marketing of Health Services/standards Neoplasms/drug therapy* Patient Compliance Research Design* Treatment Outcome*

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








You are going to have many difficulties. The smokers will not like your message. The tobacco interests will be vigorously opposed. The media and the government will be loath to support these findings. But you have one factor in your favour. What you have going for you is that you are right.
- Evarts Graham
See:
When truth is unwelcome: the first reports on smoking and lung cancer.